Epitope Mapping of 3A Protein Using Monoclonal Antibodies.

Transbound Emerg Dis

State Key Laboratory for Animal Disease Control and Prevention, Harbin Veterinary Research Institute, The Chinese Academy of Agricultural Sciences, Harbin 150069, China.

Published: May 2025


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

(SVA), an emerging pathogen causing vesicular disease in pigs, poses a significant threat to the swine industry. The nonstructural protein 3A of SVA plays an essential role in the viral replication cycle. In this study, we immunized mice with the prepared SVA 3A protein and produced two monoclonal antibodies (mAbs), AG4 and 2F3. MAb AG4 showed specific reactivity to the linear and conformational 3A protein, whereas mAb 2F3 did not recognize linear epitope of 3A protein. Through truncated 3A protein expression and alanine mutation analysis, we identified SPNEND as the minimal motif recognized by mAb AG4, with Asn being the critical residue. Additionally, we demonstrated that mAb 2F3 failed to recognize the SVA mutant with the QEETEG deletion in 3A protein, indicating that QEETEG constitutes an essential epitope for mAb 2F3. Further deletion analysis confirmed that QE is the crucial motif for mAb 2F3 recognition. Moreover, we found that SPNEND and QEETEG are highly conserved among different SVA strains and are exposed on the surface of the 3A protein. This study contributes to further explore the function of SVA 3A protein and develop diagnostic tools for SVA detection.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12077972PMC
http://dx.doi.org/10.1155/tbed/3398924DOI Listing

Publication Analysis

Top Keywords

mab 2f3
16
protein
9
monoclonal antibodies
8
sva protein
8
mab ag4
8
sva
7
mab
6
2f3
5
epitope mapping
4
mapping protein
4

Similar Publications

Epitope Mapping of 3A Protein Using Monoclonal Antibodies.

Transbound Emerg Dis

May 2025

State Key Laboratory for Animal Disease Control and Prevention, Harbin Veterinary Research Institute, The Chinese Academy of Agricultural Sciences, Harbin 150069, China.

(SVA), an emerging pathogen causing vesicular disease in pigs, poses a significant threat to the swine industry. The nonstructural protein 3A of SVA plays an essential role in the viral replication cycle. In this study, we immunized mice with the prepared SVA 3A protein and produced two monoclonal antibodies (mAbs), AG4 and 2F3.

View Article and Find Full Text PDF

The capsid protein p72 specific mAb and the corresponding novel epitope based ELISAs for detection of ASFV infection.

Vet Microbiol

April 2025

College Veterinary Medicine, Yangzhou University, China; Joint International Research Laboratory of Agriculture and Agri-Product Safety, Yangzhou University, China; Comparative Medicine Research Institute, Yangzhou University, China; Jiangsu Co-innovation Center for Prevention and Control of Importa

The African Swine Fever Virus (ASFV) poses a significant threat to the global pig farming industry. The major icosahedral capsid protein p72 plays a key role in the assembly of virus particles and infection process. As one major antigen of ASFV, p72 has been widely utilized as a marker for diagnosing infection.

View Article and Find Full Text PDF
Article Synopsis
  • The African swine fever virus (ASFV) is a harmful virus that causes severe disease in pigs and wild boars, with a genome containing over 150 proteins and a key protease, pS273R, for virion assembly and immune evasion.
  • Researchers developed two specific monoclonal antibodies (2F3 and 3C2) targeting pS273R, which were effective in various assays like ELISA and Western blotting.
  • The antibodies recognize a new conserved epitope in the pS273R protein, leading to the creation of a sensitive indirect ELISA for detecting antibodies during ASFV infection, enhancing diagnosis and vaccine development.
View Article and Find Full Text PDF

Immune checkpoint inhibitors (ICI) have been effective in treating a subset of refractory solid tumors, but only a small percentage of treated patients benefit from these therapies. Thus, there is a clinical need for reliable tools that allow for the early assessment of response to ICIs, as well as a preclinical need for imaging tools that aid in the future development and understanding of immunotherapies. Here we demonstrate that CD69, a canonical early-activation marker expressed on a variety of activated immune cells, including cytotoxic T cells and natural killer (NK) cells, is a promising biomarker for the early assessment of response to immunotherapies.

View Article and Find Full Text PDF

Preparation of a monoclonal antibody against the carcinoembryonic antigen, glypican‑3.

Mol Med Rep

May 2019

Department of Clinical Laboratory Medicine, The Second Hospital of Tianjin Medical University, Tianjin Institute of Urology, Tianjin 300211, P.R. China.

The carcinoembryonic antigen, glypican‑3 (GPC3), is a putative therapeutic target and diagnostic marker of hepatoma. In the present study, a monoclonal antibody (mAb) specifically against GPC3 was obtained via cloning the sequence of GPC3 via polymerase chain reaction and inserting it into a pET16b vector prior to transfection into Escherichia coli (E. coli) BL21.

View Article and Find Full Text PDF